Results 181 to 190 of about 7,455,679 (304)

Acute Kidney Injury After Mechanical Thrombectomy for Stroke in Patients With Pre‐Existing Renal Impairment

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Acute kidney injury (AKI) is a common but often underrecognized complication in ischemic stroke patients undergoing mechanical thrombectomy, particularly among those with pre‐existing renal impairment. This study evaluated the incidence, risk factors, and clinical impact of AKI in this high‐risk population.
Michał Borończyk, Marcel Pilarek, Emilia Jaworska, Natalia Kardas, Oliwia Barnaś, Julia Woźniak, Iga Machała, Julia Węgrzynek‐Gallina, Joanna Siuda, Anna Hawrot‐Kawecka, Anetta Lasek‐Bal   +10 more
wiley   +1 more source

Quota and Risk Sharing among Fishermen [PDF]

Pooling and exchange of random resources may offer the owners insurance and substitution. Greater efficiency and more stable revenues thereby obtain. These good properties derive from a sharing rule that complies with the core concept from cooperative ...
Bardarson, Hermann
core  

A risk sharing model for old community renewal project based on bargaining game model. [PDF]

Sci Rep
Huo X, Xue H, Xu X, Hao T, Jiao L.
europepmc   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Dynamic Risk Sharing in the United States and Europe [PDF]

This paper uses a panel VAR model to improve upon the existing literature on interregional risk sharing channels (e.g. Asdrubali, Sorensen and Yosha, 1996) in several respects.
Pierfederico Asdrubali, Soyoung Kim
core  

Evaluation of a risk-sharing agreement for atezolizumab treatment in patients with non-small cell lung cancer: a strategy to improve access in low-income countries. [PDF]

Oncologist
Arrieta O, Ramos-Ramírez M, Garcés-Flores H, Cabrera-Miranda LA, Gómez-García AP, Soto-Molina H, Cardona AF, Valencia-Velarde Á, Gálvez-Niño M, Guzmán-Vázquez S.   +9 more
europepmc   +1 more source

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket, J. Lycke, J. Salzer, F. Piehl, K. Fink, N. Lange, J. Mellergård, C. Malmeström, P. Sundström, I. Erngren, A. al‐Grety, E. Freyhult, K. Kultima, J. Burman, A. Svenningsson   +14 more
wiley   +1 more source

Consumption Risk-sharing within Australia and with New Zealand [PDF]

quantify how output risks are smoothed within Australia, and between Australia and New Zealand. About 85 percent of shocks were smoothed within Australia through credit and capital markets, with fiscal policy a source of dis-smoothing after 1992.
Sheen, Jeffrey, Kim, David
core  

Implementing performance-based risk-sharing agreements in non-small cell lung cancer immunotherapy: a real-world data case study. [PDF]

Health Econ Rev
Bártová A, Rumi F, Santos JV, Svobodník A, Rihova B.   +4 more
europepmc   +1 more source